When should stress‑dose corticosteroids be initiated in an intensive care unit patient?

When to Start Stress Dose Steroids in ICU

Start stress dose steroids immediately in ICU patients with septic shock requiring vasopressors despite adequate fluid resuscitation, using IV hydrocortisone 50-100 mg every 6-8 hours (or 200 mg/day continuous infusion). 1, 2

Clinical Scenarios Requiring Stress Dose Steroids

Septic Shock (Primary Indication)

• Initiate when: Patient has septic shock unresponsive to fluid resuscitation AND requires moderate-to-high dose vasopressors (typically ≥0.5 μg/kg/min norepinephrine equivalent) 1, 2
• Do NOT wait for ACTH stimulation test results—treatment takes precedence over diagnosis 1
• Dosing: Hydrocortisone <400 mg/day for ≥3 days at full dose 1, 2
  • Either 50-100 mg IV every 6-8 hours OR
  • 200 mg/day continuous infusion (preferred method) 3
• Duration: Continue until vasopressors are no longer required, then taper over 5-7 days 4

Acute Respiratory Distress Syndrome (ARDS)

• Initiate when: Early moderate-to-severe ARDS (PaO₂/FiO₂ <200 within 14 days of onset) 1, 2
• Dosing: IV methylprednisolone 1 mg/kg/day 1, 2

Known or Suspected Adrenal Insufficiency

Start immediately if patient presents with:

• Hemodynamic instability (hypotension refractory to fluids)
• Vomiting or diarrhea (impairs oral steroid absorption)
• Any severe physiological stress requiring ICU admission 5

Dosing for adrenal crisis:

• Hydrocortisone 100 mg IV bolus immediately 5
• Followed by 50-100 mg IV every 6-8 hours 4
• Plus aggressive fluid resuscitation (≥2L normal saline) 4

When NOT to Start Stress Dose Steroids

• Sepsis without shock: Do not use corticosteroids 1, 2
• Major trauma: Not recommended 1, 2
• Influenza: Recommend against use 6
• Hemodynamically stable patients: If adequate fluid resuscitation and vasopressor therapy restore stability, steroids are not indicated 3

Key Clinical Pitfalls

Common Error #1: Waiting for diagnostic test results before treating suspected adrenal crisis

• Random cortisol <10 μg/dL or delta cortisol <9 μg/dL after cosyntropin may support diagnosis, but never delay treatment 1, 2

Common Error #2: Using excessive doses

• Doses >400 mg/day hydrocortisone provide no additional benefit and increase adverse events 1, 2
• The 2024 meta-analysis found optimal dosing around 260 mg/day hydrocortisone equivalent 7

Common Error #3: Abrupt discontinuation

• Always taper over 5-7 days once vasopressors discontinued to prevent withdrawal and rebound hypotension 4
• Patients receiving tapers showed increased vasopressor requirements at 24 hours but ultimately better mortality outcomes 8

Special Populations

Patients on Chronic Glucocorticoids

• Any dose ≥5 mg prednisone daily for >1 month can suppress HPA axis 9
• Consider adrenal insufficiency regardless of glucocorticoid formulation (oral, inhaled, topical, intra-articular) 5
• For moderate-to-major stress: Use parenteral stress doses until stress resolves 5

Perioperative Setting

• Major surgery under general anesthesia: Hydrocortisone 100 mg IV at induction, then 200 mg/24h infusion 9
• Continue until patient recovering well, then transition to doubled oral maintenance dose for 48 hours to 1 week 9

Evidence Quality Considerations

The 2017 SCCM/ESICM guidelines 1, 2 represent the most authoritative source, with conditional recommendations based on low-to-moderate quality evidence. The 2024 focused update 10 reinforced these recommendations with stronger evidence for septic shock. The Surviving Sepsis Campaign 2016 guidelines 3 suggest hydrocortisone only when hemodynamic stability cannot be achieved with fluids and vasopressors—a more conservative threshold that aligns with current practice.

Critical distinction: The evidence supports stress dose steroids for vasopressor-dependent septic shock, not all sepsis. The benefit appears greatest in patients requiring higher vasopressor doses, with the 2024 dose-response meta-analysis 7 confirming mortality reduction at approximately 260 mg/day hydrocortisone equivalent.

Monitoring and Adverse Events

Expected adverse effects (moderate-to-high certainty):

• Hyperglycemia (target <150 mg/dL) 11, 7
• Hypernatremia 7
• Possible neuromuscular weakness with prolonged use 7

Benefits outweigh risks when appropriately indicated:

• Accelerates shock reversal (high certainty) 1, 2
• Reduces short-term mortality in septic shock (moderate certainty) 1, 2, 7
• No increased risk of secondary infections at stress doses 1, 2